Home Hospitality News Politics General News Sports Automobile Business & Finance World Technology Health & Lifestyle Opinion & Analysis Science & Environment Culture & Entertainment
Akanksha jain

Akanksha jain

Last seen: 1 month ago

Hi, I’m Akanksha, part of the editorial team. I closely monitor pharma and overall healthcare movements to provide quick, accurate, and reliable updates for our readers.

Member since Feb 16, 2026

Following (0)

Followers (0)

Health & Lifestyle
ctDNA Test May Enable Reduced Treatment for Older Breast Cancer Patients: Study

ctDNA Test May Enable Reduced Treatment for Older Breas...

A ctDNA-based test may help guide treatment de-escalation in older women with br...

Health & Lifestyle
Waves of Hope Fundraiser Supports Breast Cancer Care in Manitoba

Waves of Hope Fundraiser Supports Breast Cancer Care in...

A Waves of Hope fundraiser in Manitoba is raising funds to support breast cancer...

Health & Lifestyle
GSK Highlights Growing Role of Antibody-Drug Conjugates in Targeted Cancer Treatment

GSK Highlights Growing Role of Antibody-Drug Conjugates...

GSK outlines the scientific potential of antibody-drug conjugates (ADCs) in deli...

Health & Lifestyle
Global Health Sector Sees Surge in Collaborations, Research Advances and Policy Challenges

Global Health Sector Sees Surge in Collaborations, Rese...

New collaborations, research breakthroughs, and policy challenges are shaping th...

Health & Lifestyle
NTU, Nestlé Partner to Advance Research in Healthy Ageing and Women’s Health

NTU, Nestlé Partner to Advance Research in Healthy Agei...

NTU and Nestlé have partnered to drive research in healthy aging and women’s hea...

Health & Lifestyle
AIG Hospitals, ICMR Partner to Advance Digital Health Research in India

AIG Hospitals, ICMR Partner to Advance Digital Health R...

AIG Hospitals and ICMR have partnered to strengthen digital health research in I...

Health & Lifestyle
Replimune Skin Cancer Therapy Fails to Secure US FDA Approval Again

Replimune Skin Cancer Therapy Fails to Secure US FDA Ap...

Replimune’s experimental therapy for advanced skin cancer has failed to gain US ...

Health & Lifestyle
Codeine Cough Syrup Sold at Rs 1,000 in Parts of Madhya Pradesh, Raising Abuse Concerns

Codeine Cough Syrup Sold at Rs 1,000 in Parts of Madhya...

Codeine-based cough syrups are reportedly being sold for up to Rs 1,000 per bott...

Health & Lifestyle
Soleno Withdraws EU Rare Disease Drug Application Ahead of Neurocrine Takeover

Soleno Withdraws EU Rare Disease Drug Application Ahead...

Soleno Therapeutics has withdrawn its EU application for a rare disease drug ahe...

Health & Lifestyle
OPPI and NIPER Rae Bareli Partner to Strengthen Drug Research and Innovation in India

OPPI and NIPER Rae Bareli Partner to Strengthen Drug Re...

OPPI and NIPER Rae Bareli have partnered to advance drug research in India, focu...

Health & Lifestyle
Granules India to Strengthen Compliance Measures Following US FDA Warning

Granules India to Strengthen Compliance Measures Follow...

Granules India plans to tighten oversight and compliance systems after receiving...

Health & Lifestyle
Boston Oncology Signs Cancer Drug Deal with China’s Xuanzhu Biopharmaceutical to Expand Global Pipeline

Boston Oncology Signs Cancer Drug Deal with China’s Xua...

Boston Oncology has entered a cancer drug development deal with China’s Xuanzhu ...

Health & Lifestyle
Amazon to Offer Eli Lilly Weight Loss Pill via US Kiosks with Same-Day Delivery

Amazon to Offer Eli Lilly Weight Loss Pill via US Kiosk...

Amazon will stock Eli Lilly’s new weight loss pill at US kiosks, enabling same-d...

Health & Lifestyle
C4 Therapeutics, Roche Expand Cancer Drug Partnership in Deal Worth Over $1 Billion

C4 Therapeutics, Roche Expand Cancer Drug Partnership i...

C4 Therapeutics and Roche have expanded their cancer drug partnership with a new...

Health & Lifestyle
Sun Pharma Prepares $12 Billion Bid for Organon in Biggest Overseas Pharma Deal by Indian Firm

Sun Pharma Prepares $12 Billion Bid for Organon in Bigg...

Sun Pharma is preparing a $12 billion bid for Organon, marking the largest overs...

Health & Lifestyle
Only 7% Indians Disease-Free by 40, Apollo 2026 Report Flags Rising Lifestyle Health Risks

Only 7% Indians Disease-Free by 40, Apollo 2026 Report ...

Apollo’s Health of the Nation 2026 report reveals only 7% of Indians are disease...

We use cookies to ensure you get the best experience on our website. By continuing to browse, you agree to our use of cookies and our Privacy Policy